All Posts

Time is Brain: The EMVision Story (EMV)

Aug 3, 2026

•

9 min read

Control Bionics: A Quarter’s Worth of Progress

Jul 31, 2026

•

5 min read

The Biggest Tree in Healthcare Stands Tall

Jul 30, 2026

•

2 min read

The Human Side to Healthcare Investing

Jul 29, 2026

•

3 min read

Armchair on stage at Bio Connections

Jul 28, 2026

•

12 min read

Deep Cuts from the Surgeon: What happened with EBR?

Jul 27, 2026

•

3 min read

FDA gives the green light to peptides

Jul 24, 2026

•

3 min read

Designer Genes: The PYC Therapeutics Story (PYC)

Jul 23, 2026

•

10 min read

Tetratherix (TTX) Quarterly: 4Cing a Big Year

Jul 22, 2026

•

4 min read

The Guys Who Make Your TV Just Bet $1.8B on Peptides

Jul 21, 2026

•

3 min read

Placebo Your Bets: Prediction Markets Enter Biotech

Jul 20, 2026

•

7 min read

Eli Lilly Enters Psychedelics: The Year of the Mushroom

Jul 17, 2026

•

5 min read

1 2 3 4...15

All Posts

Time is Brain: The EMVision Story (EMV)

Control Bionics: A Quarter’s Worth of Progress

The Biggest Tree in Healthcare Stands Tall

The Human Side to Healthcare Investing

Armchair on stage at Bio Connections

Deep Cuts from the Surgeon: What happened with EBR?

FDA gives the green light to peptides

Designer Genes: The PYC Therapeutics Story (PYC)

Tetratherix (TTX) Quarterly: 4Cing a Big Year

The Guys Who Make Your TV Just Bet $1.8B on Peptides

Placebo Your Bets: Prediction Markets Enter Biotech

Eli Lilly Enters Psychedelics: The Year of the Mushroom

The Armchair Analyst